{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:09:29Z","timestamp":1778476169035,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003776","name":"Newcastle upon Tyne Hospitals NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003776","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000853","name":"University of Glasgow","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010526","name":"NHS Greater Glasgow and Clyde","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010526","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A29372"],"award-info":[{"award-number":["A29372"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005062","name":"Fujirebio Europe NV","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015250","name":"NIHR Bristol Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015250","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012805","name":"Norwich University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004922","name":"North Bristol NHS Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004922","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012324","name":"University Hospitals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014400","name":"Fujirebio US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031650","name":"Royal United Hospitals Bath NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031650","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.lungcan.2025.108670","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:48:10Z","timestamp":1752713290000},"page":"108670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Serum mesothelin as a response biomarker in pleural mesothelioma"],"prefix":"10.1016","volume":"206","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6591-2720","authenticated-orcid":false,"given":"Geraldine A.","family":"Lynch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5717-0826","authenticated-orcid":false,"given":"Jenny","family":"Symonds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Morley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emeka","family":"Azubuike-Dyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Will","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0149-4316","authenticated-orcid":false,"given":"Anthony","family":"Edey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0060-9671","authenticated-orcid":false,"given":"Duneesha De","family":"Fonseka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selina","family":"Tsim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Blyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick A.","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7386-7754","authenticated-orcid":false,"given":"Anna","family":"Bibby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.lungcan.2025.108670_b0005","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1007\/s00268-019-05132-6","article-title":"Largely Unchanged Annual Incidence and overall Survival of Pleural Mesothelioma in the USA","volume":"43","author":"Keshava","year":"2019","journal-title":"World J. Surg."},{"key":"10.1016\/j.lungcan.2025.108670_b0010","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2340\/1651-226X.2024.34802","article-title":"Patient characteristics, treatment patterns, and survival outcomes for patients with malignant pleural mesothelioma in Denmark between 2011 and 2018: a nationwide population-based cohort study","volume":"63","author":"Sorensen","year":"2024","journal-title":"Acta Oncol."},{"key":"10.1016\/j.lungcan.2025.108670_b0015","doi-asserted-by":"crossref","DOI":"10.1007\/s13665-024-00357-w","article-title":"Recent advances in Mesothelioma","author":"Lynch","year":"2024","journal-title":"Curr. Pulmonol. Rep."},{"key":"10.1016\/j.lungcan.2025.108670_b0020","unstructured":"Royal College of Physicians N ational Mesothelioma Audit Report 2020 (for the audit period 2016-18). London, RCP, 2020."},{"issue":"10272","key":"10.1016\/j.lungcan.2025.108670_b0025","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2025.108670_b0030","unstructured":"K Blyth, A.M., J McMahon, Scottish Mesothelioma Network Audit Report, Mesothelioma Quality Performance Indicators, in Clinical Audit Data: 01 January 2021 to 31 December 2021. 2021."},{"issue":"14","key":"10.1016\/j.lungcan.2025.108670_b0035","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2025.108670_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2020.10.603","article-title":"LBA1 First-line nivolumab (NIVO) plus ipilimumab (IPI) versus chemotherapy (chemo) for the treatment of unresectable malignant pleural mesothelioma (MPM): Patient-reported outcomes (PROs) from CheckMate 743","volume":"31","author":"Scherpereel","year":"2020","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2025.108670_b0045","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jtho.2018.04.034","article-title":"Revised Modified Response Evaluation Criteria in Solid Tumors for Assessment of Response in Malignant Pleural Mesothelioma (Version 1.1)","volume":"13","author":"Armato","year":"2018","journal-title":"J. Thorac. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2025.108670_b0050","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jtho.2018.05.003","article-title":"Revised Modified RECIST Criteria in Malignant Pleural Mesothelioma (Version 1.1): a step Forward in a Long race","volume":"13","author":"Tsao","year":"2018","journal-title":"J. Thorac. Oncol."},{"issue":"12","key":"10.1016\/j.lungcan.2025.108670_b0055","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1136\/thoraxjnl-2021-217808","article-title":"Fully automated volumetric measurement of malignant pleural mesothelioma by deep learning AI: validation and comparison with modified RECIST response criteria","volume":"77","author":"Kidd","year":"2022","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108670_b0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejca.2007.08.028","article-title":"Mesothelin targeted cancer immunotherapy","volume":"44","author":"Hassan","year":"2008","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108670_b0065","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004145","article-title":"Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis","volume":"4","author":"Cui","year":"2014","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.lungcan.2025.108670_b0070","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/bjc.2017.22","article-title":"Prognostication and monitoring of mesothelioma using biomarkers: a systematic review","volume":"116","author":"Arnold","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.lungcan.2025.108670_b0075","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/bjc.2015.62","article-title":"The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognostication","volume":"112","author":"Hooper","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"21","key":"10.1016\/j.lungcan.2025.108670_b0080","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1002\/cncr.28875","volume":"120","author":"Hassan","year":"2014","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.lungcan.2025.108670_b0085","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/JTO.0b013e31825f22ee","article-title":"A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma","volume":"7","author":"Nowak","year":"2012","journal-title":"J. Thorac. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108670_b0090","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1155\/2012\/430689","article-title":"Soluble mesothelin-related peptides levels in patients with malignant mesothelioma","volume":"32","author":"Franko","year":"2012","journal-title":"Dis. Markers"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108670_b0095","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1378\/chest.11-0129","article-title":"The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factor","volume":"141","author":"Hollevoet","year":"2012","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.lungcan.2025.108670_b0100","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1158\/1078-0432.CCR-10-1929","article-title":"Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden","volume":"17","author":"Creaney","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"20","key":"10.1016\/j.lungcan.2025.108670_b0105","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1200\/JCO.2009.26.9944","article-title":"Soluble mesothelin-related Peptide and osteopontin as markers of response in malignant mesothelioma","volume":"28","author":"Wheatley-Price","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.lungcan.2025.108670_b0110","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1164\/rccm.200807-1125OC","article-title":"Kinetics of soluble mesothelin in patients with malignant pleural mesothelioma during treatment","volume":"179","author":"Grigoriu","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108670_b0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12885-018-4113-3","article-title":"A prospective study to investigate the role of serial serum mesothelin in monitoring mesothelioma","volume":"18","author":"de Fonseka","year":"2018","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.lungcan.2025.108670_b0120","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1097\/JTO.0b013e3182272294","article-title":"Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma","volume":"6","author":"Hollevoet","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108670_b0125","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.lungcan.2013.05.006","article-title":"A phase II clinical trial of the vascular disrupting agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma","volume":"81","author":"Nowak","year":"2013","journal-title":"Lung Cancer"},{"issue":"28","key":"10.1016\/j.lungcan.2025.108670_b0130","doi-asserted-by":"crossref","first-page":"46425","DOI":"10.18632\/oncotarget.17436","article-title":"Prognostic significance of soluble mesothelin in malignant pleural mesothelioma: a meta-analysis","volume":"8","author":"Tian","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lungcan.2025.108670_b0135","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.lungcan.2025.108670_b0140","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J. Clin. Epidemiol."},{"issue":"11","key":"10.1016\/j.lungcan.2025.108670_b0145","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-060850","article-title":"Protocol for a prospective observational cohort study collecting data on demographics, symptoms and biomarkers in people with mesothelioma (ASSESS-meso)","volume":"12","author":"Conway","year":"2022","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108670_b0150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor biomarkers for diagnosis, prognosis and targeted therapy","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.lungcan.2025.108670_b0155","doi-asserted-by":"crossref","unstructured":"Bauml, J.M., et al., Scan-associated distress in lung cancer: Quantifying the impact of “scanxiety&#x201d. Lung Cancer, 2016. 100, p. 110\u2013113.","DOI":"10.1016\/j.lungcan.2016.08.002"},{"key":"10.1016\/j.lungcan.2025.108670_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2024.102545","article-title":"The mental health and well-being implications of a mesothelioma diagnosis: a mixed methods study","volume":"70","author":"Sherborne","year":"2024","journal-title":"Eur. J. Oncol. Nurs."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108670_b0165","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jan.13818","article-title":"The fear of needles: a systematic review and meta-analysis","volume":"75","author":"McLenon","year":"2019","journal-title":"J. Adv. Nurs."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225005628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225005628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:27:06Z","timestamp":1778473626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500225005628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":33,"alternative-id":["S0169500225005628"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108670","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum mesothelin as a response biomarker in pleural mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108670","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108670"}}